The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their ...

The United States is a key market for India’s pharmaceutical exports, with India supplying around 40 per cent of all generic ...

Presently, India imposes 10 percent tariff on Pharma imports from the United States. The US doesn't impose any tariff on ...

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new ...

Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite ...

Indian pharmaceutical stocks tumbled 4.4% on Friday, erasing gains from the previous session, after Trump threatened steep ...

India expects minimal price changes for its pharma exports under new US tariffs, as punitive measures haven’t hit the sector ...

The US president announced a 27 per cent reciprocal tariff on India, claiming the South Asian country imposes a 52 per cent ...

Of the $91 billion worth of India’s exports to the US, nearly $20 billion are expected to come under some form of exemption ...

India emerges stronger in the US-India reciprocal tariffs scenario, negotiating favorable trade agreements and protecting ...

Indian shares tumbled after President Donald Trump’s comments that the US is still considering tariffs on pharmaceutical ...

As long as pharmaceutical tariffs are being considered, their potential threat to the pharmaceutical industry and the people ...